ES2095434T3 - Nuevos derivados del 3-cicloalquil-propen-2-amida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos, y composiciones que los contienen. - Google Patents

Nuevos derivados del 3-cicloalquil-propen-2-amida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos, y composiciones que los contienen.

Info

Publication number
ES2095434T3
ES2095434T3 ES92402554T ES92402554T ES2095434T3 ES 2095434 T3 ES2095434 T3 ES 2095434T3 ES 92402554 T ES92402554 T ES 92402554T ES 92402554 T ES92402554 T ES 92402554T ES 2095434 T3 ES2095434 T3 ES 2095434T3
Authority
ES
Spain
Prior art keywords
cyclloalkyl
propen
medicines
compositions
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92402554T
Other languages
English (en)
Inventor
Elizabeth Anne Kuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919119874A external-priority patent/GB9119874D0/en
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of ES2095434T3 publication Critical patent/ES2095434T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • C07C317/40—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A DERIVADOS DE 3-CICLOALQUIL PROPEN-2-AMIDA DE FORMULA (I): EN LA QUE R1 REPRESENTA H O ALQUILO (C1-C3), W REPRESENTA O O S EVENTUALMENTE OXIDADO, Y Y Z REPRESENTAN -CH N, R2, R3, R4, R5 Y R6 REPRESENTAN H. HALOGENO, ALQUILO (C1-C4), OCH3. -SCH3, -WCF3, NO2, CN, -W(CH2)N-CF3, -W(CF2)N-CF3, -(CH2)NCX3, -(CF2)N-CF3, EN EL QUE N ES 1, 2 O 3 Y X REPRESENTA HALOGENO O R3 Y R4 FORMAN JUNTOS -O-CH2-OR7 Y R8 REPRESENTAN H O ALQUILO (C1-C6), R9 REPRESENTA CICLOALQUILO (C3-C6), A SUS FORMAS TAUTOMERAS Y A SUS SALES DE ADICION CON LAS BASES, ASI COMO A SUS PROCESO DE PREPARACION, A SU APLICACION COMO MEDICAMENTOS Y A LAS COMPOSICIONES QUE LOS CONTIENEN.
ES92402554T 1991-09-17 1992-09-17 Nuevos derivados del 3-cicloalquil-propen-2-amida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos, y composiciones que los contienen. Expired - Lifetime ES2095434T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919119874A GB9119874D0 (en) 1991-09-17 1991-09-17 3-cylopropyl-prop-2-enamide derivatives
GB929213972A GB9213972D0 (en) 1991-09-17 1992-07-01 3-cycloalkyl-prop-2-enamide derivatives

Publications (1)

Publication Number Publication Date
ES2095434T3 true ES2095434T3 (es) 1997-02-16

Family

ID=26299550

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92402554T Expired - Lifetime ES2095434T3 (es) 1991-09-17 1992-09-17 Nuevos derivados del 3-cicloalquil-propen-2-amida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos, y composiciones que los contienen.

Country Status (19)

Country Link
US (2) US5312830A (es)
EP (1) EP0533573B1 (es)
JP (1) JP3145803B2 (es)
CN (1) CN1028863C (es)
AT (1) ATE145893T1 (es)
AU (1) AU649881B2 (es)
BR (1) BR9203643A (es)
CA (1) CA2078466C (es)
CZ (1) CZ281674B6 (es)
DE (1) DE69215625T2 (es)
DK (1) DK0533573T3 (es)
ES (1) ES2095434T3 (es)
FI (1) FI111248B (es)
GR (1) GR3022423T3 (es)
HU (1) HU210164B (es)
IL (1) IL102790A (es)
MX (1) MX9205246A (es)
NO (1) NO178299C (es)
NZ (1) NZ244329A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300083D0 (en) * 1993-01-05 1993-03-03 Roussel Lab Ltd Chemical compounds
GB9313365D0 (en) * 1993-06-29 1993-08-11 Roussel Lab Ltd Chemical compounds
GB9520092D0 (en) * 1995-10-02 1995-12-06 Hoechst Roussel Ltd Chemical compounds
EP3071199A2 (en) 2013-11-22 2016-09-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases
MX2019009200A (es) * 2017-02-03 2019-10-21 Univ California Composiciones y métodos para inhibir el reticulón 4.
WO2018144869A1 (en) * 2017-02-03 2018-08-09 The Regents Of The University Of California Compositons and methods for modulating uba5
GB2588707B8 (en) * 2019-08-21 2025-08-06 William Page Roland Improved containers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4414395A (en) * 1980-03-13 1983-11-08 Ciba-Geigy Corporation Process for the manufacture of hydrazono-isoindolines
US4435407A (en) * 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
US4888357A (en) * 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
DE69002792T2 (de) * 1989-05-09 1993-12-09 Sds Biotech Corp Crotonsäureamidderivate und sie enthaltende Insektizide.
US5034410A (en) * 1989-10-11 1991-07-23 Syntex (U.S.A.) Inc. Anthelmintically active benzenepropanamide derivatives
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-cycloalkyl-propanamides their tautomer forms and their salts preparation process and compositions containing them

Also Published As

Publication number Publication date
AU649881B2 (en) 1994-06-02
EP0533573A3 (fr) 1993-05-19
HUT62555A (en) 1993-05-28
JP3145803B2 (ja) 2001-03-12
DE69215625T2 (de) 1997-04-17
NZ244329A (en) 1994-09-27
JPH05230008A (ja) 1993-09-07
AU2451692A (en) 1993-03-18
DE69215625D1 (de) 1997-01-16
HU9202942D0 (en) 1992-11-30
CN1028863C (zh) 1995-06-14
CZ265392A3 (en) 1993-06-16
CN1070637A (zh) 1993-04-07
NO923603L (no) 1993-03-18
DK0533573T3 (da) 1997-04-07
CA2078466A1 (fr) 1993-03-18
CZ281674B6 (cs) 1996-12-11
ATE145893T1 (de) 1996-12-15
FI924145L (fi) 1993-03-18
NO178299B (no) 1995-11-20
CA2078466C (fr) 2003-04-15
FI111248B (fi) 2003-06-30
HU210164B (en) 1995-02-28
MX9205246A (es) 1994-06-30
EP0533573A2 (fr) 1993-03-24
US5312830A (en) 1994-05-17
NO923603D0 (no) 1992-09-16
NO178299C (no) 1996-02-28
IL102790A (en) 1996-01-31
EP0533573B1 (fr) 1996-12-04
FI924145A0 (fi) 1992-09-16
US5389652A (en) 1995-02-14
IL102790A0 (en) 1993-01-31
BR9203643A (pt) 1993-04-13
GR3022423T3 (en) 1997-04-30

Similar Documents

Publication Publication Date Title
AR044909A1 (es) Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia
AR034475A1 (es) Derivados de androstano antiinflamatorios
CO4920234A1 (es) Derivados de acidos arilsulfonilaminomidroxamicos
ES2043617T3 (es) Un procedimiento para preparar derviados de benzamida.
DK0462812T3 (da) Pyranderivater som inhibitorer af 5-lipoxygenase
ES2132351T3 (es) Compuestos con un grupo sulfamoilo y amidino, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2066620T3 (es) Nuevos derivados de perhidroisoindol y su preparacion.
ES2058292T3 (es) Derivados de indol.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2123652T3 (es) 7-(2-aminoetil)-benzotiazolonas.
CO5590895A2 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos
ES2086341T3 (es) Derivados de aminoacidos con propiedades inhibidoras de la renina, procedimiento para su preparacion, agentes que los contienen y su utilizacion.
ES2095434T3 (es) Nuevos derivados del 3-cicloalquil-propen-2-amida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos, y composiciones que los contienen.
CO5700762A2 (es) 3-fluoro-piperidinas como antagonistas de nmda/nr2b
ES2152237T3 (es) Pirazolo(4,3-c)piridinas, un procedimiento para su preparacion y su uso como inhibidores de la recaptacion de serotonina.
ES2095848T3 (es) Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos.
ES2060127T3 (es) Halogenoalquilfenil-alcoholes-cetonas y sus hidratos.
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
ECSP088455A (es) Nuevos derivados de indolizina, su proceso de preparación y las composiciones terapéuticas que los comprenden
MX9400274A (es) Nuevos derivados 2-ciano-3-hidroxipropenamidas, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ES2043515B1 (es) Procedimiento para la preparacion de nuevos derivados de 1-difenilmetilpiperazina.
ES2059550T3 (es) Derivados de la bencimidazola, su preparacion y su aplicacion en terapeutica.
ES2058831T3 (es) Derivados de la 1-arilsulfonil-2-piperidinona, su procedimiento y los compuestos intermedios de preparacion, su aplicacion como medicamentos y composiciones que los contienen.
MX9205921A (es) Derivados de bis(fenil)etano, proceso para su preparacion y composicion farmaceutica que los contiene
HRP20030712B1 (hr) Derivati kaloporozida, postupci za njihovu proizvodnju i njihova upotreba

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 533573

Country of ref document: ES